The launch enables JSW
Steel to tap the growing opportunity for tinplate products demanded by India's packaging industry.
He is on an acquisition spree in an effort to give his $11-billion JSW
Group even greater heft and scale.
Steel has also submitted an expression of interest ( EOI) for Tata Steel UK and is now waiting for a goahead from the Tatas.
extruder will be used in the production of LDPE in one of the downstream derivative plants in Sasol's new petrochemical complex, which utilizes ethane gas.
Under this contract, which has a value of about USD540m, Toshiba JSW
will carry out Engineering, Procurement, Construction (EPC) of the entire thermal power plant, including civil and boiler island package to be completed within 48 months from the contract award.
will seek to take advantage of the increasing demand in the US in order to cut its debt and improve profitability, he explained.
India's third largest producer of the metal, JSW
Steel, rival Jindal Steel and Power and two others are in the race to buy Stemcor's iron ore mine and iron processing facilities.
With the completion of merger, JSW
Steel has become the second largest steel producer in the country after state-owned Steel Authority of India (SAIL) with 14.3 million tonnes capacity.
The first is what JSW
terms a "melter," and its purpose is to mimic what occurs inside a polymer reactor (see illustration).
Under the agreement, JFE Steel, which has a 15% stake in JSW
Steel, will provide assistance to develop various grades of steel, such as "JFE-HITEN" high-strength steel and steel sheets for automotive external panels, including JAZ highly lubricated galvannealed steel sheet, to meet diverse, high-end demands from automakers with production bases in India.
It was reported today that QPS LLC, a full-service GLP/GCP-compliant contract research organisation that provides testing services to support pre-clinical and clinical research and development, has acquired a majority interest in JSW
Life Sciences GmbH, a company that provides pre-clinical and clinical Phase II-IV drug development services to pharmaceutical and biotech companies worldwide.